Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2013
Title: Marta Dziechciarkova: Innovator in Cancer Therapy Sensitivity Determination
Introduction
Marta Dziechciarkova is a prominent inventor based in Olomouc, Czech Republic. She has made significant contributions to the field of cancer therapy through her innovative methods. Her work focuses on improving the sensitivity determination of patients suffering from cancer diseases to biological therapies.
Latest Patents
Marta holds a patent for a method that determines the sensitivity of cancer patients to targeted biological therapy. This invention is particularly relevant as it involves the inhibition of signaling pathways of the HER family members, such as HER-1, HER-2, HER-3, and HER-4. The method assesses the expression of the biomarker S6 kinase and its post-translationally modified forms in tumors, which is crucial for tailoring effective treatment plans.
Career Highlights
Throughout her career, Marta has been associated with several esteemed institutions. She has worked at Palacký University in Olomouc, the Faculty of Medicine, and the Masaryk Institute of Oncology. Her academic and research endeavors have significantly advanced the understanding of cancer therapies.
Collaborations
Marta has collaborated with notable colleagues, including Marian Hajduch and Lenka Radova. Their joint efforts have contributed to the development of innovative solutions in cancer treatment.
Conclusion
Marta Dziechciarkova's work exemplifies the impact of innovation in the medical field, particularly in cancer therapy. Her patented method for determining patient sensitivity to biological therapy represents a significant advancement in personalized medicine.